Business
Currency:USD
2024/FY
Stock NameRevenueRatio
FILSPARI132.22M56.71%
Tiopronin products94.49M40.52%
License and collaboration revenue6.47M2.77%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States233.18M100.00%